Inova in the News
Baxter IV shortage: Inova’s immediate recommendations for urology practices
The Impact of Hurricane Helene Destruction of Baxter Factory: Immediate Recommendations for Urology Practices in United States to Preserve IV (Intravenous) and other Fluids By Inger Rosner, MD and J. Stephen Jones, MDInova Health System, Fairfax VA Hurricane Helene has caused widespread devastation, resulting in loss of life, homes, and businesses. A significant consequence of…
Read More“Want to give back to your community immediately? Donate blood or host a blood drive,” WTOP, February 22, 2024
Every 2 seconds, someone in the United States needs blood. One blood donation can save up to three lives. Nicholas Lilly, senior director of Inova Blood Donor Services spoke with WTOP as part of their 2024 Get on Top of Your Health series.
Read MoreCancer-free “Voice of DC” shares message of hope
Known as the “Voice of DC,” WTOP reporter Neal Augenstein continues to share his inspiring journey from a stage-4 lung cancer diagnosis in November 2022 to becoming cancer-free a year later. Last week, Neal’s story of the ground-breaking medical treatment he received at Inova Schar Cancer was featured on NBC News. In the piece, Amit…
Read MoreDr. Stephen Jones: Prosecuting nurses for honest mistakes won’t make patients safer
Inova’s president and CEO J. Stephen Jones, MD, MBA, FACS had an op-ed piece published in USA Today following Friday’s sentencing of nurse RaDonda Vaught. (While working as a nurse at Vanderbilt University Medical Center in 2017, Vaught’s accidental administration of the wrong drug to a patient led to the patient’s death. Vaught was later…
Read MoreDr. Stephen Jones: It’s time for us to step up for healthcare workers
The Richmond Times-Dispatch has published an op-ed piece by Inova President and CEO J. Stephen Jones, MD, MBA, FACS, that articulates the issue of increasing physical and emotional violence directed at healthcare workers. Jones describes several recent incidents at Inova, including a nurse being told by a patient that the patient only wanted to “be…
Read MoreIs Radiation Necessary After Breast Cancer Surgery?
Ductal carcinoma in situ (DCIS) is a cancer that forms in the cells that line the milk ducts, and it accounts for 20% of new breast cancer diagnoses. The most common treatment is breast-conserving surgery to remove the cancerous tissue. While only a small percentage of women experience an invasive cancer event following surgery, radiation…
Read MoreAntibody Infusions May Speed Recovery from COVID-19
As reported by Julie Carey for NBC-4 Washington, when Inova ER physician Dr. Chris Sponaugle contracted COVID-19, he also became a patient – at one of Inova’s monoclonal antibody infusion clinics, which opened in mid-December at three Northern Virgnia locations. Sponaugle did not experience negative side effects and was happy to receive the treatment, which…
Read MoreABC-7: ‘Brilliant thinkers’ help Inova reach 100,000 COVID vaccinations
On February 4, ABC-7 WJLA reported that Inova had achieved the milestone of 100,000 COVID-19 vaccines given in 53 days. Inova CEO Dr. Stephen Jones remarked [that] “Two months ago, we didn’t know we would be in the vaccination business. And suddenly it came and what these folks said is, ‘We’ll do what it takes…
Read MoreCOVID-19 Vaccine Rollout at Inova: 35k Doses Given So Far
Inova has vaccinated 35,000-plus Northern Virginia healthcare workers, first responders, teachers and other eligible populations as of January 14, due in no small part to dedicated teams of specialists working in concert to move vaccine recipients through the process smoothly. Originally aiming to vaccinate somewhere between 1,000 and 1,500 per day, the Inova clinic has…
Read MoreInova’s Dr. Aragon-Ching Part of International Team Showing Benefit of Immunotherapy in Bladder Cancer Treatment
Jeanny B. Aragon-Ching, MD of the Inova Schar Cancer Institute has co-authored a groundbreaking bladder cancer research paper just published in the New England Journal of Medicine. The large phase III clinical study showed that the addition of immunotherapy with Avelumab (Bavencio) increased the duration of overall survival by almost 50% in patients when given…
Read More